Scan Science and Technology
Contact Leading Edge Experts & Companies
Anti Influenza
The Experts below are selected from a list of 17742 Experts worldwide ranked by ideXlab platform
Shin-ichiro Nishimura – One of the best experts on this subject based on the ideXlab platform.
-
Novel trivalent Anti–Influenza reagent
Bioorganic & Medicinal Chemistry Letters, 2010Co-Authors: Fei Feng, Nobuaki Miura, Norikazu Isoda, Yoshihiro Sakoda, Masatoshi Okamatsu, Hiroshi Kida, Shin-ichiro NishimuraAbstract:Abstract We designed and synthesized novel trivalent Anti–Influenza reagents. Sialyllactose was located at the terminal of each valence which aimed to block each receptor-binding site of the hemagglutinin (HA) trimer on the surface of the virus. Structural analyses were carried out with a model which was constructed with a computer simulation. A previously reported cyclic glycopeptide blocker [Ohta, T.; Miura, N.; Fujitani, N.; Nakajima, F.; Niikura, K.; Sadamoto, R.; Guo, C.-T.; Suzuki, T.; Suzuki, Y.; Monde, K.; Nishimura, S.-I. Angew. Chem. Int. Ed. , 2003 , 42 , 5186] bound to the HA in the model. The analyses suggest that the glutamine residue in the cyclic peptide bearing Neu5Acα2,3Galβ1,4Glc trisaccharide via a linker interacts with the Gln189 in HA through hydrogen bonding. The present Anti–Influenza reagents likely interact with a glutamine residue included in the vicinity of Gln189. A plague reduction assay of the Influenza virus, A/PR/8/1934 (H1N1), was performed in MDCK cells to evaluate for the synthesized compounds to inhibit viral replication. One of the compounds showed approximately 85% inhibition at the concentration of 400 μM at 4 °C.
-
Novel trivalent Anti–Influenza reagent
Bioorganic & Medicinal Chemistry Letters, 2010Co-Authors: Fei Feng, Nobuaki Miura, Norikazu Isoda, Yoshihiro Sakoda, Masatoshi Okamatsu, Hiroshi Kida, Shin-ichiro NishimuraAbstract:Abstract We designed and synthesized novel trivalent Anti–Influenza reagents. Sialyllactose was located at the terminal of each valence which aimed to block each receptor-binding site of the hemagglutinin (HA) trimer on the surface of the virus. Structural analyses were carried out with a model which was constructed with a computer simulation. A previously reported cyclic glycopeptide blocker [Ohta, T.; Miura, N.; Fujitani, N.; Nakajima, F.; Niikura, K.; Sadamoto, R.; Guo, C.-T.; Suzuki, T.; Suzuki, Y.; Monde, K.; Nishimura, S.-I. Angew. Chem. Int. Ed. , 2003 , 42 , 5186] bound to the HA in the model. The analyses suggest that the glutamine residue in the cyclic peptide bearing Neu5Acα2,3Galβ1,4Glc trisaccharide via a linker interacts with the Gln189 in HA through hydrogen bonding. The present Anti–Influenza reagents likely interact with a glutamine residue included in the vicinity of Gln189. A plague reduction assay of the Influenza virus, A/PR/8/1934 (H1N1), was performed in MDCK cells to evaluate for the synthesized compounds to inhibit viral replication. One of the compounds showed approximately 85% inhibition at the concentration of 400 μM at 4 °C.
Fei Feng – One of the best experts on this subject based on the ideXlab platform.
-
Novel trivalent Anti–Influenza reagent
Bioorganic & Medicinal Chemistry Letters, 2010Co-Authors: Fei Feng, Nobuaki Miura, Norikazu Isoda, Yoshihiro Sakoda, Masatoshi Okamatsu, Hiroshi Kida, Shin-ichiro NishimuraAbstract:Abstract We designed and synthesized novel trivalent Anti–Influenza reagents. Sialyllactose was located at the terminal of each valence which aimed to block each receptor-binding site of the hemagglutinin (HA) trimer on the surface of the virus. Structural analyses were carried out with a model which was constructed with a computer simulation. A previously reported cyclic glycopeptide blocker [Ohta, T.; Miura, N.; Fujitani, N.; Nakajima, F.; Niikura, K.; Sadamoto, R.; Guo, C.-T.; Suzuki, T.; Suzuki, Y.; Monde, K.; Nishimura, S.-I. Angew. Chem. Int. Ed. , 2003 , 42 , 5186] bound to the HA in the model. The analyses suggest that the glutamine residue in the cyclic peptide bearing Neu5Acα2,3Galβ1,4Glc trisaccharide via a linker interacts with the Gln189 in HA through hydrogen bonding. The present Anti–Influenza reagents likely interact with a glutamine residue included in the vicinity of Gln189. A plague reduction assay of the Influenza virus, A/PR/8/1934 (H1N1), was performed in MDCK cells to evaluate for the synthesized compounds to inhibit viral replication. One of the compounds showed approximately 85% inhibition at the concentration of 400 μM at 4 °C.
-
Novel trivalent Anti–Influenza reagent
Bioorganic & Medicinal Chemistry Letters, 2010Co-Authors: Fei Feng, Nobuaki Miura, Norikazu Isoda, Yoshihiro Sakoda, Masatoshi Okamatsu, Hiroshi Kida, Shin-ichiro NishimuraAbstract:Abstract We designed and synthesized novel trivalent Anti–Influenza reagents. Sialyllactose was located at the terminal of each valence which aimed to block each receptor-binding site of the hemagglutinin (HA) trimer on the surface of the virus. Structural analyses were carried out with a model which was constructed with a computer simulation. A previously reported cyclic glycopeptide blocker [Ohta, T.; Miura, N.; Fujitani, N.; Nakajima, F.; Niikura, K.; Sadamoto, R.; Guo, C.-T.; Suzuki, T.; Suzuki, Y.; Monde, K.; Nishimura, S.-I. Angew. Chem. Int. Ed. , 2003 , 42 , 5186] bound to the HA in the model. The analyses suggest that the glutamine residue in the cyclic peptide bearing Neu5Acα2,3Galβ1,4Glc trisaccharide via a linker interacts with the Gln189 in HA through hydrogen bonding. The present Anti–Influenza reagents likely interact with a glutamine residue included in the vicinity of Gln189. A plague reduction assay of the Influenza virus, A/PR/8/1934 (H1N1), was performed in MDCK cells to evaluate for the synthesized compounds to inhibit viral replication. One of the compounds showed approximately 85% inhibition at the concentration of 400 μM at 4 °C.
Xiaorong Wang – One of the best experts on this subject based on the ideXlab platform.
-
Anti–Influenza agents from plants and traditional Chinese medicine.
Phytotherapy research : PTR, 2006Co-Authors: Xiaoyan Wang, Wei Jia, Aihua Zhao, Xiaorong WangAbstract:Influenza is a serious threat to health in all parts of the world. The control and treatment of Influenza depends mainly on chemical or biochemical agents and, to date, some Anti–Influenza agents have been isolated from plants as a result of chemical and pharmacological studies. These agents include a variety of polyphenols, flavonoids, saponins, glucosides and alkaloids. Traditional medicine focuses on the use of herbs and traditional Chinese medicine has performed well in clinical practice and shows a potential in the therapy of Influenza and its symptoms. The present paper reviews some constituents and extracts from plants and traditional Chinese medicine with Anti–Influenza activity.